NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/13/2024
Back to search
Official data from USPTO
UNITED CLINICAL TRIALS NETWORK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
UNITED CLINICAL TRIALS NETWORK
ST13
US500000098057170Class
42
Filing
98057170
Registration
7471828
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
08/13/2024
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
06/23/2023
Registration date
08/13/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2024
Last transaction
08/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/06/2023
First use in commerce
06/06/2023
Drawing code
4
Owner type
16
Owner location
Rockford, MI, US
Examiner
CHADAB, SETH
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
United Clinical Trials Network, LLC
Representatives
United Clinical Trials Network, LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Clinical research in the field of investigational drug studies; Clinical research in the field of observational studies; Clinical research in the field of device studies; Pharmaceutical research and development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Basic and clinical research in the field of respiratory science and medicine; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Laboratory research services relating to pharmaceuticals; Medical and scientific researchconducting clinical trials for others; Providing a website featuring educational information in the field of clinical research; Providing information in the field of clinical research via a website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of investigational drug studies; Scientific research in the nature of conducting clinical trials for others in the field of observational studies; Scientific research in the nature of conducting clinical trials for others in the field of medical device studies; Technical research in the field of pharmaceutical studies; Testinginspection or research of pharmaceuticalscosmetics or foodstuff; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/28/2024
PUBO
PUBLISHED FOR OPPOSITION
05/28/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/23/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/23/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/20/2024
GNRT
NON-FINAL ACTION E-MAILED
03/20/2024
CNRT
NON-FINAL ACTION WRITTEN
03/20/2024
DOCK
ASSIGNED TO EXAMINER
03/11/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/02/2023
NWAP
NEW APPLICATION ENTERED
06/27/2023
Continuous trademark protection
Get notified about every new filing that threatens UNITED CLINICAL TRIALS NETWORK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.